Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Barriers in Hepatitis C Treatment in Somali Patients in the Direct Acting Antiviral Therapy Era.

Journal of the National Medical Association - 1 Dec 2018

Elwir Saleh, Anugwom Chimaobi, Connor Esther K, Giama Nasra H, Ndzengue Albert, Menk Jeremiah, Mohamed Essa A, Roberts Lewis R, Hassan Mohamed

Abstract excerpt

BACKGROUND AND AIMS: Hepatitis C virus (HCV) treatment has changed dramatically in the last few years. Our observations suggest that a minority of HCV infected Somalis are treated. In this study, we aimed to evaluate for treatment and health outcome disparities between Somali and non-Somali patients during the direct acting antiviral (DAA) era. METHODS: Patients with HCV seen in the gastroenterology clinic in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Asymptomatic Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Insurance, Health

Share to Minnesota

Share to Patient Acceptance of Health Care

Share to Patient Selection

Share to Sustained Virologic Response

Source

Identifiers

PMID: 30129499
DOI: 10.1016/j.jnma.2018.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Barriers in Hepatitis C Treatment in Somali Patients in the Direct Acting Antiviral Therapy Era.PMID 30129499Read ↗

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study.Semantic proximity Read ↗

Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.Semantic proximity Read ↗

Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.Semantic proximity Read ↗

Challenges of hepatitis C treatment in Native Americans in two North Dakota medical facilities.Semantic proximity Read ↗

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapiesSemantic proximity Read ↗

Hepatitis C in an urban cohort: who's not being treated?Semantic proximity Read ↗

Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.Semantic proximity Read ↗

Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.Semantic proximity Read ↗

Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.Semantic proximity Read ↗

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.Semantic proximity Read ↗

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.